Nadkarni; Sunil Sadanand

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nadkarni; Sunil Sadanand.The latest application filed is for "pharmaceutical composition of tapentadol for parenteral administration".

Company Profile

0.14.18

Nadkarni; Sunil Sadanand - Gujarat N/A IN
Nadkarni; Sunil Sadanand - Gandhinagar IN
Nadkarni; Sunil Sadanand - Bhat IN
Nadkarni; Sunil Sadanand - Memnagar Ahmedabad IN
Nadkarni; Sunil Sadanand - Dist. Gandhinagar IN
Nadkarni; Sunil Sadanand - Ahmedabad IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical composition of tapentadol for nasal administration Grant 11,413,239 - Nadkarni , et al. August 16, 2	2022-08-16
Pharmaceutical composition of tapentadol for parenteral administration Grant 9,629,818 - Nadkarni , et al. April 25, 2	2017-04-25
Pharmaceutical Composition Of Tapentadol For Parenteral Administration App 20150290146 - Nadkarni; Sunil Sadanand ; et al.	2015-10-15
Acid addition salts of risperidone and pharmaceutical compositions thereof Grant 9,040,695 - Nadkarni , et al. May 26, 2	2015-05-26
Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof App 20140243278 - Nadkarni; Sunil Sadanand ; et al.	2014-08-28
Pharmaceutical Invention Of Tapentadol App 20140170209 - Nadkarni; Sunil Sadanand ; et al.	2014-06-19
Acid Addition Salts Of Risperidone And Pharmaceutical Compositions Thereof App 20140045864 - Nadkarni; Sunil Sadanand ; et al.	2014-02-13
Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol Grant 8,633,241 - Attanti , et al. January 21, 2	2014-01-21
Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol Grant 8,604,222 - Sheth , et al. December 10, 2	2013-12-10
Nebivolol and its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol App 20130296583 - Sheth; Rakesh ; et al.	2013-11-07
Modified release composition for highly soluble drugs Grant 8,268,352 - Vaya , et al. September 18, 2	2012-09-18
Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients Grant 8,263,125 - Vaya , et al. September 11, 2	2012-09-11
Modified release composition of highly soluble drugs Grant 8,216,609 - Vaya , et al. July 10, 2	2012-07-10
Dosage form Grant 7,985,422 - Vaya , et al. July 26, 2	2011-07-26
Modified release composition of highly soluble drugs Grant 7,976,871 - Vaya , et al. July 12, 2	2011-07-12
Controlled release formulation of lamotrigine App 20110123618 - Nadkarni; Sunil Sadanand	2011-05-26
Controlled release formulation of lamotrigine Grant 7,939,102 - Nadkarni , et al. May 10, 2	2011-05-10
Montelukast Benzhydryl Piperazine Salts And Process For Preparation Thereof App 20100292251 - Shimpi; Nitin Ashok ; et al.	2010-11-18
2-Propene-1-Ones As Hsp 70 Inducers App 20080207608 - Kumar; Prabhat ; et al.	2008-08-28
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor App 20080096863 - Nagaria; Rahul Maheshchandra ; et al.	2008-04-24
Nebivolol and Its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol App 20070259950 - Sheth; Rakesh ; et al.	2007-11-08
Process for preparation of polymorphic form of sertraline hydrochloride App 20060167113 - Nadkarni; Sunil Sadanand	2006-07-27
Novel drug delivery system App 20060018934 - Vaya; Navin ; et al.	2006-01-26
Novel drug delivery system App 20060018933 - Vaya; Navin ; et al.	2006-01-26
Novel dosage form App 20040096499 - Vaya, Navin ; et al.	2004-05-20
Controlled release formulation of lamotrigine App 20040043996 - Nadkarni, Sunil Sadanand	2004-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.